APPLICATION
ANDA078988
TYPE
ANDA
ORIGINAL APPROVAL
2008-06-09
LATEST ACTION
2024-06-05
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
PREDNISOLONE SODIUM PHOSPHATEPrescription
PREDNISOLONE SODIUM PHOSPHATE EQ 20MG BASE/5ML · SOLUTION · ORAL
Approval history
2024-06-05Labeling · Supplement 11 · standardAP
2010-03-24Labeling · Supplement 5AP
2008-06-09OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.